Explore the Underlying Mechanism Between Atopic Dermatitis and Major Depressive Disorder

Area of Science:

• Immunodermatology
• Neuropsychiatry
• Computational Biology

Background:

• Adult patients with atopic dermatitis (AD) exhibit elevated rates of major depressive disorder (MDD).
• The precise biological mechanisms connecting AD and MDD remain largely unelucidated.
• Understanding these links is crucial for developing integrated treatment strategies.

Purpose of the Study:

• To identify molecular and genetic entities linking atopic dermatitis (AD) and major depressive disorder (MDD) using data mining and expression analysis.
• To investigate the functional pathways through which AD may influence the development of MDD.
• To explore the role of specific genes, small molecules, and cellular components in the AD-MDD relationship.

Main Methods:

• Systematic literature-based data mining to identify entities connecting AD and MDD.
• Mega-analysis of AD-RNA expression data to assess MDD gene regulator expression variance.
• Pathway enrichment analysis (PEA) using Fisher Exact test to determine functional roles.

Main Results:

• Identified 22 upstream regulators of MDD driven by AD, including 11 genes, 7 small molecules, 3 functional classes, and 1 cell type.
• Four of the identified genes showed significant expression changes in AD patients, correlating with MDD development.
• Pathway analysis indicated AD primarily influences MDD pathogenesis through cytokine/chemokine regulation and neuroinflammatory response pathways.

Conclusions:

• Atopic dermatitis plays a promoting role in the pathological development of major depressive disorder.
• The link between AD and MDD involves the regulation of multiple genetic factors implicated in cytokine/chemokine signaling and inflammatory responses.
• These findings highlight the importance of considering immune and inflammatory mechanisms in the comorbidity of AD and MDD.